<p>In a new study, <a href="https://search.asu.edu/profile/3942692">Jeffrey Kordower</a>, director of the <a href="https://biodesign.asu.edu/neurodegenerative-disease/">ASU-Banner Neurodegenerative Disease Research Center</a>, and his colleagues unveil pivotal insights into the progression of Parkinson's disease, presenting new hope for patients battling the severely debilitating disorder.</p>
<p>The research highlights the role of a critical protein called tau in the early stages of the disease. The results suggest that aggregates of the tau protein may jump-start processes of neuronal damage and death characteristics of the disease.</p>